Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 03 04 2020
accepted: 30 07 2020
entrez: 12 10 2020
pubmed: 13 10 2020
medline: 21 5 2021
Statut: epublish

Résumé

Hepatitis B virus (HBV) is a global virus responsible for a universal disease burden for millions of people. Various vaccination strategies have been developed using viral vector, nucleic acid, protein, peptide, and virus-like particles (VLPs) to stimulate favorable immune responses against HBV. Given the pivotal role of specific immune responses of hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) in infection control, we designed a VLP-based vaccine by placing the antibody-binding fragments of HBsAg in the major immunodominant region (MIR) epitope of HBcAg to stimulate multilateral immunity. A computational approach was employed to predict and evaluate the conservation, antigenicity, allergenicity, and immunogenicity of the construct. Modeling and molecular dynamics (MD) demonstrated the folding stability of HBcAg as a carrier in inserting Myrcludex and "a" determinant of HBsAg. Regions 1-50 and 118-150 of HBsAg were considered to have the highest stability to be involved in the designed vaccine. Molecular docking revealed appropriate interactions between the B cell epitope of the designed vaccine and the antibodies. Totally, the final construct was promising for inducing humoral and cellular responses against HBV.

Identifiants

pubmed: 33042118
doi: 10.3389/fimmu.2020.02074
pmc: PMC7521014
doi:

Substances chimiques

Hepatitis B Vaccines 0
Immunodominant Epitopes 0
Immunoglobulin Fab Fragments 0
L protein, hepatitis B virus 0
Vaccines, Virus-Like Particle 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2074

Informations de copyright

Copyright © 2020 Mobini, Chizari, Mafakher, Rismani and Rismani.

Références

Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15016-21
pubmed: 18809920
Hepatology. 2005 Jun;41(6):1383-90
pubmed: 15915462
BMC Bioinformatics. 2005 May 31;6:132
pubmed: 15927070
Hepatology. 2009 Apr;49(4):1132-40
pubmed: 19140219
Front Immunol. 2019 Sep 20;10:2240
pubmed: 31620140
Emerg Microbes Infect. 2013 Mar;2(3):e15
pubmed: 26038456
World J Gastroenterol. 2014 May 14;20(18):5427-34
pubmed: 24833873
Proteins. 2013 Feb;81(2):229-39
pubmed: 22972754
Bioinformatics. 2005 Apr 1;21(7):951-60
pubmed: 15531603
Med Microbiol Immunol. 2015 Feb;204(1):39-55
pubmed: 25523195
J Viral Hepat. 2014 Dec;21(12):860-72
pubmed: 24498958
Bioinformatics. 2010 Dec 1;26(23):2936-43
pubmed: 20934990
Cold Spring Harb Perspect Med. 2015 May 01;5(5):a021436
pubmed: 25934462
Proteins. 2011;79 Suppl 10:147-60
pubmed: 22069036
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
Cell Mol Immunol. 2019 Nov 25;:
pubmed: 31767976
Adv Enzymol Relat Areas Mol Biol. 1978;47:45-148
pubmed: 364941
Med Microbiol Immunol. 2015 Feb;204(1):57-68
pubmed: 25557605
J Immunol. 2015 Nov 15;195(10):4873-83
pubmed: 26416274
Annu Rev Immunol. 2019 Apr 26;37:457-495
pubmed: 30676822
Immunome Res. 2006 Apr 24;2:2
pubmed: 16635264
Sci Rep. 2017 Aug 15;7(1):8145
pubmed: 28811664
Proteins. 2003 Feb 15;50(3):437-50
pubmed: 12557186
J Hepatol. 2011 Jul;55(1):29-37
pubmed: 21145866
J Viral Hepat. 2005 Mar;12(2):111-24
pubmed: 15720525
Mol Cell. 1999 Jun;3(6):771-80
pubmed: 10394365
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W202-9
pubmed: 16844994
BMC Bioinformatics. 2007 Jan 05;8:4
pubmed: 17207271
Methods Enzymol. 1997;277:396-404
pubmed: 9379925
J Virol. 2007 Apr;81(8):4215-25
pubmed: 17287266
Expert Rev Vaccines. 2013 Feb;12(2):183-98
pubmed: 23414409
Aliment Pharmacol Ther. 2019 May;49(10):1346-1359
pubmed: 30982998
Viruses. 2009 Sep;1(2):185-209
pubmed: 21994545
Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):363-9
pubmed: 23924493
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29
pubmed: 28472356
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W407-10
pubmed: 17517781
J Virol. 1985 Sep;55(3):836-9
pubmed: 2991600
Arch Virol. 2016 Oct;161(10):2765-72
pubmed: 27439498
Hum Vaccin Immunother. 2015;11(2):407-10
pubmed: 25692622
J Microbiol Biotechnol. 2018 Aug 28;28(8):1376-1383
pubmed: 30301315
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Vaccine. 2008 Apr 7;26(16):1972-81
pubmed: 18343539
Bioinformatics. 2012 Oct 15;28(20):2608-14
pubmed: 23053206
Proteins. 2019 Jun;87(6):520-527
pubmed: 30785653
BMC Bioinformatics. 2007 Jul 04;8:238
pubmed: 17608956
Immunology. 2009 Feb;126(2):280-9
pubmed: 18624732
J Mol Model. 2014 Jun;20(6):2278
pubmed: 24878803
Methods Enzymol. 1996;266:525-39
pubmed: 8743704
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558
pubmed: 30981686
Hepatology. 2018 Apr;67(4):1560-1599
pubmed: 29405329
Science. 2012 Nov 30;338(6111):1220-5
pubmed: 23197535
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Intervirology. 2001;44(2-3):98-114
pubmed: 11509871
Methods Mol Biol. 2014;1079:105-16
pubmed: 24170397
Expert Opin Ther Targets. 2017 Dec;21(12):1153-1159
pubmed: 29065733
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Sci Rep. 2017 May 16;7(1):1990
pubmed: 28512348
Iran J Allergy Asthma Immunol. 2015 Jun;14(3):233-45
pubmed: 26546891
FEBS Lett. 1990 Dec 10;276(1-2):172-4
pubmed: 1702393
Nucleic Acids Res. 2014 Jan;42(Database issue):D1140-6
pubmed: 24214988
J Virol. 2004 Jun;78(11):5707-19
pubmed: 15140968
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
PLoS One. 2010 Apr 16;5(4):e9862
pubmed: 20419125
BMC Bioinformatics. 2008 Dec 02;9:514
pubmed: 19055730

Auteurs

Saeed Mobini (S)

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Milad Chizari (M)

Department of Medical Biotechnology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.

Ladan Mafakher (L)

Medicinal Plant Research Center, Ahvaz Jundishapur of Medical Science, Ahvaz, Iran.

Elmira Rismani (E)

Department of Biology, Payam Noor University, Tehran, Iran.

Elham Rismani (E)

Molecular Medicine Department, Pasteur Institute of Iran, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH